Drug Information

Drug General Information
Drug ID
D0R2HF
Former ID
DNC013517
Drug Name
6-(2-mercaptoacetamido)-N-phenylhexanamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529285]
Structure
Download
2D MOL

3D MOL
Formula
C14H20N2O2S
Canonical SMILES
C1=CC=C(C=C1)NC(=O)CCCCCNC(=O)CS
InChI
1S/C14H20N2O2S/c17-13(16-12-7-3-1-4-8-12)9-5-2-6-10-15-14(18)11-19/h1,3-4,7-8,19H,2,5-6,9-11H2,(H,15,18)(H,16,17)
InChIKey
ICMLRCZXRBTKLJ-UHFFFAOYSA-N
PubChem Compound ID
11437457
Target and Pathway
Target(s) Histone Deacetylase 8 Target Info Inhibitor [529285]
KEGG Pathway Alcoholism
Viral carcinogenesis
PANTHER Pathway Wnt signaling pathway
Pathway Interaction Database Signaling events mediated by HDAC Class I
Reactome NOTCH1 Intracellular Domain Regulates Transcription
Constitutive Signaling by NOTCH1 PEST Domain Mutants
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
HDACs deacetylate histones
WikiPathways Integrated Pancreatic Cancer Pathway
Neural Crest Differentiation
Cell Cycle
References
Ref 529285J Med Chem. 2008 Mar 27;51(6):1505-29. Epub 2008 Feb 5.Histone deacetylase inhibitors: from bench to clinic.
Ref 529285J Med Chem. 2008 Mar 27;51(6):1505-29. Epub 2008 Feb 5.Histone deacetylase inhibitors: from bench to clinic.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.